Med-IQ CME: ATTR-CM Treatment: Changing the Paradigm
This CME activity discusses the diagnosis and treatment of ATTR-CM and highlights key updates on ATTR-CM treatment presented at the HFSA Annual Scientific Meeting 2025 and AHA Scientific Sessions 2025.
Cost: Free
View Offer chevron_rightKey Features
Key updates on ATTR-CM treatment from recent meetings.
Topics Covered
ATTR-CM
Learning Objectives
1. Contrast new and emerging treatment options for ATTR-CM with historical pharmacotherapy
2. Incorporate new and emerging therapies into the care of patients with ATTR-CM
Target Audience
This activity is intended for cardiologists.
Additional credit info
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.